{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:05:22Z","timestamp":1766268322777,"version":"3.44.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This manuscript is endorsed and funded by the International Society for Pharmacoepidemiology (ISPE)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13216-4","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:36:59Z","timestamp":1758875819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Electronic data sources for drug utilization research and healthcare decision-making in Mexico"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3086-446X","authenticated-orcid":false,"given":"Yared","family":"Santa-Ana-Tellez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-2330","authenticated-orcid":false,"given":"Anah\u00ed","family":"Dreser Mansilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6724-6441","authenticated-orcid":false,"given":"Lucila Isabel","family":"Castro Pastrana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-1558","authenticated-orcid":false,"given":"Maribel","family":"Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2796-2440","authenticated-orcid":false,"given":"Juan Carlos","family":"S\u00e1nchez Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-2228","authenticated-orcid":false,"given":"Diana","family":"G\u00f3mez-Galicia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-8960","authenticated-orcid":false,"given":"Lisiane","family":"Freitas Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3684-3275","authenticated-orcid":false,"given":"Luciane","family":"Cruz Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"13216_CR1","doi-asserted-by":"crossref","unstructured":"Elseviers M, editor. Drug utilization research: methods and applications. John Wiley & Sons Inc: Chichester, West Sussex: Hoboken, NJ, 2016.","DOI":"10.1002\/9781118949740"},{"key":"13216_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00228-013-1496-6","volume":"69","author":"B Wettermark","year":"2013","unstructured":"Wettermark B. The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol. 2013;69:43\u201351.","journal-title":"Eur J Clin Pharmacol"},{"key":"13216_CR3","volume-title":"The World Medicines Situation 2011","author":"A Cameron","year":"2011","unstructured":"Cameron A, Ewen M, Auton M, Abegunde D. The World Medicines Situation 2011. 3rd ed. World Health Organization; 2011.","edition":"3"},{"key":"13216_CR4","volume-title":"Introduction to drug utilization research","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Introduction to drug utilization research. World Health Organization: Geneva,2003."},{"key":"13216_CR5","unstructured":"WHO Global Observatory for eHealth. Atlas of eHealth country profiles: the use of eHealth in support of universal health coverage: based on the findings of the third global survey on eHealth. 2015. World Health Organization: Geneva, 2016. (accessed 2 Nov 2023). https:\/\/iris.who.int\/handle\/10665\/204523"},{"key":"13216_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(08)61762-6","volume":"373","author":"A Cameron","year":"2009","unstructured":"Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373:240\u20139.","journal-title":"Lancet"},{"key":"13216_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","volume":"14","author":"TP Van Boeckel","year":"2014","unstructured":"Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742\u201350.","journal-title":"Lancet Infect Dis"},{"key":"13216_CR8","doi-asserted-by":"publisher","DOI":"10.1590\/S1020-49892010000300009","author":"VJ Wirtz","year":"2010","unstructured":"Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997\u20132007. Rev Panam Salud Publica. 2010. https:\/\/doi.org\/10.1590\/S1020-49892010000300009.","journal-title":"Rev Panam Salud Publica"},{"key":"13216_CR9","unstructured":"Pharmexcil. Mexico Pharma Market & Regulatory Report. 2020.https:\/\/pharmexcil.com\/uploads\/countryreports\/Mexico_Market_Regulatory_report2020.pdf"},{"key":"13216_CR10","first-page":"1","volume":"22","author":"M\u00c1 Gonz\u00e1lez Block","year":"2020","unstructured":"Gonz\u00e1lez Block M\u00c1, Reyes Morales H, Hurtado LC, Balandr\u00e1n A, M\u00e9ndez E. Mexico: health system review. Health Syst Transit. 2020;22:1\u2013222.","journal-title":"Health Syst Transit"},{"key":"13216_CR11","unstructured":"Oropeza Ab\u00fandez C, editor. Encuesta Nacional de Salud y nutrici\u00f3n 2018-19: resultados nacionales. Primera Edici\u00f3n. Cuernavaca, Morelos, M\u00e9xico: Instituto Nacional de Salud P\u00fablica; 2020."},{"key":"13216_CR12","doi-asserted-by":"publisher","first-page":"e1763114","DOI":"10.1080\/23288604.2020.1763114","volume":"6","author":"MR Reich","year":"2020","unstructured":"Reich MR. Restructuring health reform, Mexican style. Health Syst Reform. 2020;6:e1763114.","journal-title":"Health Syst Reform"},{"key":"13216_CR13","doi-asserted-by":"publisher","first-page":"e004669","DOI":"10.1136\/bmjopen-2013-004669","volume":"4","author":"R P\u00e9rez-Cuevas","year":"2014","unstructured":"P\u00e9rez-Cuevas R, Doubova SV, Wirtz VJ, Servan-Mori E, Dreser A, Hern\u00e1ndez-\u00c1vila M. Effects of the expansion of doctors\u2019 offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey. BMJ Open. 2014;4:e004669.","journal-title":"BMJ Open"},{"key":"13216_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/heapol\/czz164","volume":"35","author":"SV Doubova","year":"2020","unstructured":"Doubova SV, Knaul FM, Borja-Aburto VH, Garcia-Sa\u00edso S, Zapata-Tarres M, Gonzalez-Leon M, et al. Access to paediatric cancer care treatment in Mexico: responding to health system challenges and opportunities. Health Policy Plann. 2020;35:291\u2013301.","journal-title":"Health Policy Plann"},{"key":"13216_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pds.4989","volume":"29","author":"M Salas","year":"2020","unstructured":"Salas M, Lopes LC, Godman B, Truter I, Hartzema AG, Wettermark B, et al. Challenges facing drug utilization research in the Latin American region. Pharmacoepidemiol Drug Saf. 2020;29:1353\u201363.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"13216_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/pds.5404","volume":"31","author":"LC Lopes","year":"2022","unstructured":"Lopes LC, Salas M, Osorio-de\u2010Castro CGS, Leal LF, Doubova SV, Ca\u00f1\u00e1s M, et al. Data sources for drug utilization research in Latin American countries\u2014a cross\u2010national study: DASDUR\u2010LATAM study. Pharmacoepidemiol Drug. 2022;31:343\u201352.","journal-title":"Pharmacoepidemiol Drug"},{"key":"13216_CR17","unstructured":"IQVIA. Research Support. (accessed 2 Nov 2023). https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/research-support"},{"key":"13216_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/tmi.12096","volume":"18","author":"VJ Wirtz","year":"2013","unstructured":"Wirtz VJ, Herrera-Patino JJ, Santa\u2010Ana\u2010Tellez Y, Dreser A, Elseviers M, Vander Stichele RH. Analysing policy interventions to prohibit over\u2010the\u2010counter antibiotic sales in four Latin American countries. Trop Med Int Health. 2013;18:665\u201373.","journal-title":"Trop Med Int Health"},{"key":"13216_CR19","doi-asserted-by":"publisher","first-page":"e75550","DOI":"10.1371\/journal.pone.0075550","volume":"8","author":"Y Santa-Ana-Tellez","year":"2013","unstructured":"Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HGM, Wirtz VJ. Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS ONE. 2013;8:e75550.","journal-title":"PLoS ONE"},{"key":"13216_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.03629-14","volume":"59","author":"Y Santa-Ana-Tellez","year":"2015","unstructured":"Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HGM, Wirtz VJ. Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions. Antimicrob Agents Chemother. 2015;59:105\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"13216_CR21","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/heapol\/czw066","volume":"31","author":"Y Santa-Ana-Tellez","year":"2016","unstructured":"Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HGM, Wirtz VJ. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis. Health Policy Plan. 2016;31:1291\u20136.","journal-title":"Health Policy Plan"},{"key":"13216_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.sapharm.2005.10.001","volume":"2","author":"M Altagracia-Mart\u00ednez","year":"2006","unstructured":"Altagracia-Mart\u00ednez M, Kravzov-Jinich J, Guadarrama-Atrizco MD, Rubio-Poo C, Wertheimer AI. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory? Res Social Administrative Pharm. 2006;2:22\u201337.","journal-title":"Res Social Administrative Pharm"},{"key":"13216_CR23","doi-asserted-by":"publisher","first-page":"2084221","DOI":"10.1080\/23288604.2022.2084221","volume":"8","author":"O G\u00f3mez-Dant\u00e9s","year":"2022","unstructured":"G\u00f3mez-Dant\u00e9s O, Dreser A, Wirtz VJ, Reich MR. Challenges of guaranteeing access to medicines in Mexico: lessons from recent changes in pharmaceuticals procurement. Health Syst Reform. 2022;8:2084221.","journal-title":"Health Syst Reform"},{"key":"13216_CR24","doi-asserted-by":"publisher","DOI":"10.4172\/2472-1042.1000116","author":"A Acosta","year":"2018","unstructured":"Acosta A, Basto S, Fonseca MF, Duran C, Vargas C, Rovira J. Description of drug pricing and procurement information web portals in some Latin American countries. Pharmacoeconomics. 2018. https:\/\/doi.org\/10.4172\/2472-1042.1000116.","journal-title":"Pharmacoeconomics"},{"key":"13216_CR25","doi-asserted-by":"publisher","DOI":"10.1787\/9789264197305-en","author":"OECD","year":"2013","unstructured":"OECD. Public procurement review of the state\u2019s employees\u2019 Social Security and Social Services Institute in Mexico. OECD. 2013. https:\/\/doi.org\/10.1787\/9789264197305-en","journal-title":"OECD"},{"key":"13216_CR26","unstructured":"CENSIDA. SALVAR - \u00bfC\u00f3mo surge? Centro Nacional para Prevencion y Control del VIH y el SIDA. gob.mx. http:\/\/www.gob.mx\/censida\/documentos\/salvar-como-surge (accessed 2 Nov 2023)."},{"key":"13216_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21149\/spm.v57s2.7606","volume":"57","author":"CG V\u00e9ronique Chaumont","year":"2015","unstructured":"V\u00e9ronique Chaumont CG, Bautista-Arredondo S, Calva JJ, Bahena-Gonz\u00e1lez RI, S\u00e1nchez-Ju\u00e1rez GH, Gonz\u00e1lez de Araujo-Muriel A, et al. Antiretroviral purchasing and prescription practices in Mexico constraints, challenges and opportunities. Salud Publica Mex. 2015;57:171.","journal-title":"Salud Publica Mex"},{"key":"13216_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21149\/spm.v57s2.7599","volume":"57","author":"S Bautista Arredondo","year":"2015","unstructured":"Bautista Arredondo S, Silverman-Retana O, Serv\u00e1n-Mori E, Lozano R. Mortalidad temprana por sida en M\u00e9xico durante el periodo 2008\u20132012. Salud Publica Mex. 2015;57:119.","journal-title":"Salud Publica Mex"},{"key":"13216_CR29","unstructured":"INAI. Instituto Nacional de Transparencia, Acceso a la Informaci\u00f3n y Protecci\u00f3n de Datos Personales. https:\/\/home.inai.org.mx\/"},{"key":"13216_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.vhri.2019.04.006","volume":"20","author":"D Moye-Holz","year":"2019","unstructured":"Moye-Holz D, van Dijk JP, Reijneveld SA, Hogerzeil HV. The impact of price negotiations on public procurement prices and access to 8 innovative cancer medicines in a middle- income country: the case of Mexico. Value Health Reg Issues. 2019;20:129\u201335.","journal-title":"Value Health Reg Issues"},{"key":"13216_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1472-6947-12-50","volume":"12","author":"R P\u00e9rez-Cuevas","year":"2012","unstructured":"P\u00e9rez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, et al. Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. BMC Med Inf Decis Mak. 2012;12:50.","journal-title":"BMC Med Inf Decis Mak"},{"key":"13216_CR32","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1097\/HJH.0b013e3283613090","volume":"31","author":"SV Doubova","year":"2013","unstructured":"Doubova SV, Lamadrid-Figueroa H, P\u00e9rez-Cuevas R. Use of electronic health records to evaluate the quality of care for hypertensive patients in Mexican family medicine clinics. J Hypertens. 2013;31:1714\u201323.","journal-title":"J Hypertens"},{"key":"13216_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2393-14-168","volume":"14","author":"SV Doubova","year":"2014","unstructured":"Doubova SV, P\u00e9rez-Cuevas R, Ortiz-Panozo E, Hern\u00e1ndez-Prado B. Evaluation of the quality of antenatal care using electronic health record information in family medicine clinics of Mexico City. BMC Pregnancy Childbirth. 2014;14:168.","journal-title":"BMC Pregnancy Childbirth"},{"key":"13216_CR34","doi-asserted-by":"crossref","unstructured":"Doubova SV, Perez-Cuevas R. Quality of care for hip and knee osteoarthritis at family medicine clinics: lessons from Mexico. Int J Qual Health Care. 2015;mzv003.","DOI":"10.1093\/intqhc\/mzv003"},{"key":"13216_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bmhimx.2015.07.003","volume":"72","author":"SV Doubova","year":"2015","unstructured":"Doubova SV, Perez-Cuevas R, Balandr\u00e1n-Duarte DA, Rend\u00f3n-Mac\u00edas ME. Quality of care for children with upper respiratory infections at Mexican family medicine clinics. Bolet\u00edn M\u00e9dico Del Hosp Infantil De M\u00e9xico. 2015;72:235\u201341.","journal-title":"Bolet\u00edn M\u00e9dico Del Hosp Infantil De M\u00e9xico"},{"key":"13216_CR36","unstructured":"ISSSTE. Con modernos sistemas de control de medicamentos, el ISSSTE garantiza abasto del 95 por ciento. gob.mx. (accessed 2 Nov 2023). http:\/\/www.gob.mx\/issste\/prensa\/con-modernos-sistemas-de-control-de-medicamentos-el-issste-garantiza-abasto-del-95-por-ciento"},{"key":"13216_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.21149\/14643","volume":"65","author":"R Lehmann-Mendoza","year":"2023","unstructured":"Lehmann-Mendoza R, Rios-Villalba P, Cort\u00e9s-Moreno GY, Gonz\u00e1lez-Mundo I, Torres-Valdes LA, Peregrino-Rodr\u00edguez G, et al. S\u00edndrome Poscovid en derechohabientes de Petr\u00f3leos Mexicanos, 2020\u20132022. Salud Publica Mex. 2023;65:305\u20136.","journal-title":"Salud Publica Mex"},{"key":"13216_CR38","unstructured":"SEDENA. Modernizaci\u00f3n y actualizaci\u00f3n del sistema digital de Sanidad (MD-45). Memoria documental. 2018. https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/420339\/45_M.D._MODERNIZACION_SISTEMA_DIGITAL_SANIDAD.pdf"},{"key":"13216_CR39","unstructured":"SEMAR. Direcci\u00f3n General Adjunta de Sanidad Naval. Sistema de Control Hospitalario SICOHOSP. Secretar\u00eda de Marina Armada de M\u00e9xico. (accessed 15 Jan2024). https:\/\/docplayer.es\/62345396-Sistema-de-control-hospitalario-sicohosp.html"},{"key":"13216_CR40","unstructured":"Gonz\u00e1lez-Gonz\u00e1les L, M\u00e1rquez-Ram\u00edrez D, Castro de \u00c1ngel C, Calzada Mijangos M, Palacio-Me\u00edja L, Jaimes H, et al. Sospechas de reacciones adversas a medicamentos atiinflamatorios no esteroideos (AINES).19 Congreso de Investigaci\u00f3n en Salud P\u00fablica. M\u00e9xico: Cuernavaca; 2023. https:\/\/congisp.espm.mx\/"},{"key":"13216_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-981-15-2724-1_7","volume-title":"Global Pharmaceutical Policy","author":"D Moye-Holz","year":"2020","unstructured":"Moye-Holz D, Dreser A, G\u00f3mez-Dant\u00e9s O, Wirtz VJ. Promoting access to cancer medicines in Mexico: Seguro Popular key policy components. In: Babar, Z-U-D, editors. Global Pharmaceutical Policy. Singapore: Springer; 2020. p. 177\u2013222."},{"key":"13216_CR42","unstructured":"OCAMIS. El Observatorio Ciudadano para el Acceso a Medicamentos e Insumos para la Salud OCAMIS: Documento de Partida. Observatorio Ciudadano para el Acceso a Medicamentos e Insumos para la Salud. 2022.https:\/\/ocamis.org\/"},{"key":"13216_CR43","unstructured":"Encuesta Nacional de Salud y Nutrici\u00f3n. ENCUESTAS. https:\/\/ensanut.insp.mx\/index.php (accessed 2 Nov 2023)."},{"key":"13216_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.21149\/14186","volume":"64","author":"M Romero-Mart\u00ednez","year":"2022","unstructured":"Romero-Mart\u00ednez M, Barrientos-Guti\u00e9rrez T, Cuevas-Nasu L, Bautista-Arrendondo S, Colchero MA, Gaona-Pineda EB, et al. Metodolog\u00eda de la Encuesta Nacional de Salud y Nutrici\u00f3n 2022 y Planeaci\u00f3n y Dise\u00f1o de la Ensanut Continua 2020\u20132024. Salud Publica Mex. 2022;64:522\u20139.","journal-title":"Salud Publica Mex"},{"key":"13216_CR45","doi-asserted-by":"publisher","first-page":"e0136823","DOI":"10.1371\/journal.pone.0136823","volume":"10","author":"E Servan-Mori","year":"2015","unstructured":"Servan-Mori E, Heredia-Pi I, Monta\u00f1ez-Hernandez J, Avila-Burgos L, Wirtz VJ. Access to medicines by Seguro Popular beneficiaries: pending tasks towards universal health coverage. PLoS ONE. 2015;10:e0136823.","journal-title":"PLoS ONE"},{"key":"13216_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1590\/S0036-36342010000100006","volume":"52","author":"VJ Wirtz","year":"2010","unstructured":"Wirtz VJ, Russo G, Kageyama-Escobar M, de la L. Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006. Salud P\u00fablica M\u00e9x. 2010;52:30\u20138.","journal-title":"Salud P\u00fablica M\u00e9x"},{"key":"13216_CR47","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/1475-6773.12404","volume":"51","author":"M Rivera-Hernandez","year":"2016","unstructured":"Rivera-Hernandez M, Rahman M, Mor V, Galarraga O. The impact of social health insurance on diabetes and hypertension process indicators among older adults in Mexico. Health Serv Res. 2016;51:1323\u201346.","journal-title":"Health Serv Res"},{"key":"13216_CR48","unstructured":"C\u00f3digo F, Presenta COFEPRIS. VigiFlow, la nueva herramienta de notificaciones para la farmacovigilancia. 2019.https:\/\/codigof.mx\/presenta-cofepris-vigiflow-la-nueva-herramienta-de-notificaciones-para-la-farmacovigilancia\/ (accessed 2 Nov 2023)."},{"key":"13216_CR49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40290-023-00490-y","volume":"37","author":"G Ray\u00f3n-Ram\u00edrez","year":"2023","unstructured":"Ray\u00f3n-Ram\u00edrez G, Alvarado-L\u00f3pez S, Camacho-Sandoval R, Loera MJ, Svarch AE, Alcocer-Varela J. Strengthening the pharmacovigilance system in Mexico: implementation of Vigi Flow and VigiLyze, as ICSR and signal detection management systems. Pharm Med. 2023;37:425\u201337.","journal-title":"Pharm Med"},{"key":"13216_CR50","first-page":"162","volume":"23","author":"JA Aedo","year":"2023","unstructured":"Aedo JA, Figueiredo L, Vidal NG, Mampasso JC, Ram\u00edrez JCP, S\u00e1nchez JET. Red Iberoamericana de Programas Posconsumo de Medicamentos: pasado, presente y futuro. Revista De Salud Ambiental. 2023;23:162\u201373.","journal-title":"Revista De Salud Ambiental"},{"key":"13216_CR51","unstructured":"SINGREM, Estadisticas. https:\/\/www.singrem.org.mx\/estadisticas.html (accessed 2 Nov2023)."},{"key":"13216_CR52","unstructured":"Carvalho-Silva R-G. Salgado-Machuca, Ibarra-C\u00e1zares. Estudio comparativo de la disposici\u00f3n de antibi\u00f3ticos en los contenedores del SINGREM de la Ciudad de M\u00e9xico, Morelos y Puebla antes, durante y despu\u00e9s del periodo de contingencia del sismo en 2017. VII Congreso Nacional de Uso Racional de Medicamentos y II Congreso de La Red Latinoamericana Para El Uso Seguro de Medicamentos. Mexico; 2019."},{"key":"13216_CR53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1248\/bpb.b22-00790","volume":"46","author":"EA Quintana-Salazar","year":"2023","unstructured":"Quintana-Salazar EA, Reyes-Mendoza M, Heyerdahl-Viau I, Aedo-Sordo JA, Prado-Galbarro FJ, Mart\u00ednez-N\u00fa\u00f1ez JM. Economic cost of the waste of anti-inflammatory and analgesic drugs in Mexico City. Biol Pharm Bull. 2023;46:781\u20137.","journal-title":"Biol Pharm Bull"},{"key":"13216_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/pds.3896","volume":"25","author":"CE Dur\u00e1n","year":"2016","unstructured":"Dur\u00e1n CE, Christiaens T, Acosta \u00c1, Vander Stichele R. Systematic review of cross-national drug utilization studies in Latin America: methods and comparability: cross-national DU studies in Latin America. Pharmacoepidemiol Drug Saf. 2016;25:16\u201325.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"13216_CR55","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00038-014-0564-8","volume":"59","author":"P Ferrer","year":"2014","unstructured":"Ferrer P, Ballar\u00edn E, Sabat\u00e9 M, Laporte J-R, Schoonen M, Rottenkolber M, et al. Sources of European drug consumption data at a country level. Int J Public Health. 2014;59:877\u201387.","journal-title":"Int J Public Health"},{"key":"13216_CR56","doi-asserted-by":"publisher","first-page":"e3339","DOI":"10.18294\/sc.2021.3339","volume":"17","author":"M Ca\u00f1\u00e1s","year":"2021","unstructured":"Ca\u00f1\u00e1s M, Mar\u00edn GH, Urtasun MA, Leal LF, Salas M, Elseviers M, et al. Data transparency for building a stronger healthcare system: a case study from Argentinean administrative drug utilization data sources. Salud Colectiva. 2021;17:e3339.","journal-title":"Salud Colectiva"},{"key":"13216_CR57","first-page":"1","volume":"5","author":"SK Neme-Meunier","year":"2019","unstructured":"Neme-Meunier SK. A 20 a\u00f1os de la implementaci\u00f3n del expediente cl\u00ednico electr\u00f3nico en M\u00e9xico. Bolet\u00edn CONAMED. 2019;5:1\u201318.","journal-title":"Bolet\u00edn CONAMED"},{"key":"13216_CR58","unstructured":"Diario Oficial de La Federacion. ACUERDO que modifica el Anexo \u00danico del diverso por el que se declara la obligatoriedad de la Estrategia Nacional de Acci\u00f3n contra la Resistencia a los Antimicrobianos, publicado el 5 de junio de 2018. 2022. https:\/\/dof.gob.mx\/nota_detalle.php?codigo=5525043&amp;fecha=05\/06\/2018"},{"key":"13216_CR59","doi-asserted-by":"publisher","first-page":"1047946","DOI":"10.3389\/fphar.2022.1047946","volume":"13","author":"LY Rodr\u00edguez-Tanta","year":"2023","unstructured":"Rodr\u00edguez-Tanta LY, Garavito Farro H, Freitas Leal L, Salas M, Elseviers MM, Lopes LC. Drug utilization research in Peru: is real-world data available? Front Pharmacol. 2023;13:1047946.","journal-title":"Front Pharmacol"},{"key":"13216_CR60","doi-asserted-by":"publisher","first-page":"708","DOI":"10.21149\/spm.v58i6.8299","volume":"58","author":"E Denova-Guti\u00e9rrez","year":"2016","unstructured":"Denova-Guti\u00e9rrez E, Flores YN, Gallegos-Carrillo K, Ram\u00edrez-Palacios P, Rivera-Paredez B, Mu\u00f1oz-Aguirre P, et al. Health workers cohort study: methods and study design. Salud Publica Mex. 2016;58:708.","journal-title":"Salud Publica Mex"},{"key":"13216_CR61","first-page":"5555274","volume":"1","author":"J Ortega-Montiel","year":"2023","unstructured":"Ortega-Montiel J, Montoya A, Soria-Saucedo R, Gallegos-Carrillo K, Ram\u00edrez-Palacios P, Salmer\u00f3n J, Salazar-Mart\u00ednez E. Trends of antihypertensive, antidiabetic, and nonsteroidal anti-Inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018. Adv Pharmacol Pharm Sci. 2023;1:5555274.","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"13216_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/BF03261979","volume":"35","author":"B S\u00e1nchez-S\u00e1nchez","year":"2012","unstructured":"S\u00e1nchez-S\u00e1nchez B, Altagracia-Mart\u00ednez M, Kravzov-Jinich J, Moreno-Bonett C, V\u00e1zquez-Moreno E, Mart\u00ednez-N\u00fa\u00f1ez JM. Evaluation of completeness of suspected adverse drug reaction reports submitted to the Mexican National Pharmacovigilance Centre: a cross-sectional period-prevalence study. Drug Saf. 2012;35:837\u201344.","journal-title":"Drug Saf"},{"key":"13216_CR63","unstructured":"Alc\u00e1ntara-Acevedo L. Aplicaci\u00f3n de Algoritmos Estandarizados internacionalmente para evaluar Notificaciones Espontaneas de Sospecha de Reacci\u00f3n Adversa en el CNFV del a\u00f1o 2010. [Tesis de Licenciatura]. Licenciatura en Qu\u00edmica Farmac\u00e9utico Biol\u00f3gica, FES-Zaragoza, UNAM, M\u00e9xico. 2010."},{"key":"13216_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/amiajnl-2012-000907","volume":"20","author":"JE Hern\u00e1ndez-\u00c1vila","year":"2013","unstructured":"Hern\u00e1ndez-\u00c1vila JE, Palacio-Mej\u00eda LS, Lara-Esqueda A, Silvestre E, Agudelo-Botero M, Diana ML, et al. Assessing the process of designing and implementing electronic health records in a statewide public health system: the case of Colima, Mexico. J Am Med Inf Assoc. 2013;20:238\u201344.","journal-title":"J Am Med Inf Assoc"},{"key":"13216_CR65","first-page":"199","volume":"20","author":"J Mancilla-Galindo","year":"2021","unstructured":"Mancilla-Galindo J, Garc\u00eda-M\u00e9ndez J\u00d3, M\u00e1rquez-S\u00e1nchez J, Reyes-Casarrubias RE, Aguirre-Aguilar E, Rocha-Gonz\u00e1lez HI, Kammar-Garc\u00eda A. All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: a real-world observational study. EXCLI J. 2021;20:199\u2013222.","journal-title":"EXCLI J"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13216-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13216-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:03:02Z","timestamp":1758880982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13216-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13216"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13216-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1214"}}